Obesity Clinical Trial
Official title:
Behavioral Economics Concepts Influencing Healthy Food Choice - Pilot 2
This is the second in a series of pilot interventions we are conducting to assess how principles from behavioral economics can be applied to improve consumers' food choices. In collaboration with Aramark, the food service vendor, we intend to examine if calorie labeling in different formats impacts consumers choice of bottled beverages in hospital cafeterias. Specifically, we will be testing whether signage that conveys to consumers the number of calories in each bottled beverage will increase the number of zero-calorie beverages sold relative to non-zero-calorie beverages. Likewise, we will test whether signage that conveys calories in exercise equivalents increases the sale of zero-calorie beverages. Lastly, we will test if signage conveying standard calorie information in conjunction with exercise equivalents increases the sale of zero-calorie beverages. We will measure the differential effect of each of these three formats for calorie information.
Individual behavior plays a central role in the disease burden faced by society. Many major
health problems in the United States such as obesity are exacerbated by unhealthy behaviors.
In our research, we apply ideas from behavioral economics, which integrates concepts from
psychology and economics, to the problem of changing health behaviors. In our research we
use several of the decision biases that ordinarily lead people to self-harming behavior, to
promote healthy behaviors instead. To date, we have been applying this approach to areas
such as smoking cessation, weight loss and medication compliance. We were approached by
Aramark to collaborate on projects to test the applicability of this approach to changing
food choice. Successful pilots in this area would greatly contribute to ongoing discussions
nationally on curbing the obesity epidemic. Our plan was to structure interventions to take
advantage of the fact that individuals put disproportionate value on present relative to
future costs and benefits, known as present-biased preferences. Present-biased preferences
can be made to steer people toward healthier options if they are given immediate rewards for
healthy behaviors with even small rewards, if they are immediate. Our first project with
Aramark used price discounts on zero-calorie beverages as a means to make the benefits of
healthier beverage choice more immediate and tangible. At 4 Aramark hospital cafeteria
sites, we discounted the price of zero-calorie beverages by 10% and sought to determine the
impact on consumers choice of these beverages. At this time, the intervention has just
completed, and data analysis is ongoing. Besides financial incentives, as we used in our
first pilot project, conveying information can also make the value of future costs and
benefits more immediate. It is this principle which we plan to test with the second pilot.
This pilot intervention will use a quasi-experimental, factorial design to test the impact
of calorie information presented on posters in different formats on beverage choice
(zero-calorie beverage versus other drinks). At each of 4 hospital cafeteria sites, we will
conduct 3 separate, consecutive interventions in which we post the following displays for
bottled beverages: (A) calorie information, (B) calories plus calories as exercise
equivalents, (C) calories as exercise equivalents. Each intervention will last 3 weeks with
a 1 week "washout" period (no display) in between interventions. Therefore, the
interventions will run for a total of 11 weeks. The order of interventions will be
randomized at each site to address ordering effects. Data on bottled beverage sales
(zero-calorie vs. non-zero-calorie) will be collected and analyzed at the cafeteria-level.
This includes point-of-sale data, inventory, and stock-keeping-units (SKU) data of
zero-calorie and regular beverages sold weekly at each site, before, during and after the
pilot. In order to make appropriate comparisons across cafeterias, already-conducted
site-specific demographic market research analysis on customers (in aggregate) will also be
considered. No individual-level consumer data will be collected, obtained, or analyzed in
this study.
The unit of analysis for these studies are hospital cafeterias and cafes which are operated
by Aramark, the food services company. The cafeterias and cafes are located in a variety of
hospitals located nationwide. Through discussions with Aramark, these cafeterias have
volunteered to participate in this study. Representatives from Aramark have been in contact
with representatives from the hospitals regarding their participation. We expect 4 Aramark
sites will participate, which in total will include 6 cafeterias and 3 convenience stores.
During the intervention, customers at each site will see the calorie information displays
but will be under no obligation to purchase any of the beverages involved in the study.
The 11 week intervention is set to begin in early February. Data on beverage sales at each
site will be collected in the weeks and months leading up to the intervention and in the
weeks and months following the intervention.
There will be no individual-level data collection, only aggregate monitoring of cafeteria
beverage inventory. As such there is almost no risk to human subjects, their privacy, or
confidentiality.
Potential risks to humans include altered food choice that negatively affects their health.
Though we will be promoting healthier options, there is a very small possibility that such
promotion paradoxically may influence individuals to seek out less healthy items. There is
also a small risk of such promotions such as exercise labeling to effect individuals
psychologically in unexpected ways. The likelihood of both of these is very small and the
seriousness of these risks also are minor.
;
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |